LC-MS/MS Based Method Development for the Monitoring of Antibiotic Concentrations in Sputum of Cystic Fibrosis Patients

NCT02840136 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

40

Enrollment

OTHER

Sponsor class

Stopped Lack of staff

Conditions

Cystic Fibrosis

Interventions

DRUG: Piperacillin-tazobactam combination product
DRUG: Meropenem
DRUG: Ceftazidime

Sponsor

University Ghent

Collaborators

[object Object]
[object Object]